A group of researchers at Kyushu University developed a covalent drug, YH-6, to help treat COVID-19. Professor Akio Ojida and his team succeeded in reducing the activity of an enzyme protein that supports in-body coronavirus multiplication. The discovery was published in the Journal of Medicinal Chemistry, and further research will be made to seek regulatory approval for YH-6. Source: Pharmaceutical Sciences Kyushu University
Get Fukuoka & Kyushu area news and events in English regularly. Sign up for our free weekly newsletter. Opt out at any time and privacy is protected. Get the “Now”
Disclaimer: These summaries are from publicly posted contents. Errors might occur during translation. Images are sourced independently for illustrative purposes and credited appropriately. Use this form to send feedback or ask for edits.
